NEWTOWN, Pa. , Oct. 3, 2025 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating potential violations of the federal securities laws involving CarMax, Inc. (NYSE: KMX), resulting from allegations of providing potentially misleading business information to the investing public. ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In CTO To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in CTO between February 18, 2021 and June 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP also encourages anyone with information regarding CTO's conduct to contact the firm, incl ...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Car-Mart, Inc. ("Car-Mart†or the "Company†) (NASDAQ:CRMT) investors concerning the Company's possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On July 15, 2025, Car-Mart disclosed it would delay filing its annual report because "management identified the need to enhance disclosures related to lo. ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Novo Nordisk A/S due to allegations of misleading statements regarding the company's growth potential and market capabilities, particularly related to its GLP-1 products [3][4]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses exceeding $100,000 in Novo between May 7, 2025, and July 28, 2025, to contact them for discussing legal options [1]. - A federal securities class action has been filed against Novo, with a deadline of September 30, 2025, for investors to seek the role of lead plaintiff [1][5]. Group 2: Allegations Against Novo - The complaint alleges that Novo and its executives violated federal securities laws by making false or misleading statements and failing to disclose the true state of the company's growth potential [3]. - Specific claims include that Novo's potential to capitalize on the compounded market was greatly understated, and the likelihood of patients switching to Novo's branded alternatives was overstated [3]. Group 3: Stock Performance Impact - Following Novo's announcement of lowered sales and profit outlook on July 29, 2025, the company's stock price fell from $69.00 per share on July 28, 2025, to $53.94 per share on July 29, 2025, marking a decline of approximately 21.83% in one day [4].

Core Viewpoint - A lawsuit has been filed against Lineage, Inc. and its senior executives for potential violations of federal securities laws related to its IPO and subsequent financial performance [1][2]. Group 1: Lawsuit Details - Investors have until September 30, 2025, to request to lead the case, which is based on claims under Sections 11 and 15 of the Securities Act of 1933 [2]. - The lawsuit is pending in the U.S. District Court for the Eastern District of Michigan, specifically titled City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., et al. [2]. Group 2: Company Overview - Lineage, Inc. operates as a cold storage-focused real estate investment trust (REIT), owning and managing temperature-controlled storage facilities for perishable products [3]. Group 3: Allegations and Financial Performance - The IPO documents claimed that Lineage had "consistent cold chain demand" and strong cash flows, suggesting resilience during economic stress, while the reality was a downturn due to customers destocking excess inventory from the pandemic [4]. - Following the IPO on July 25, 2024, at $78 per share, Lineage's stock price has significantly declined to around $40 per share, approximately 50% of its initial value [5].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Dow Inc. for possible violations of federal securities laws and unlawful business practices, following a significant drop in Dow's stock price after disappointing financial results [2][3]. Financial Performance - Dow reported net sales of $10.1 billion for Q2 2025, which represents a 7% decrease year-over-year and a 3% decline sequentially. The decline was attributed to reduced performance across all operating segments, despite some seasonal demand in Performance Materials & Coatings [3]. Stock Price Reaction - Following the announcement of its financial results, Dow's stock price fell by $5.30 per share, equating to a 17.45% drop, closing at $25.07 per share on July 24, 2025 [3]. Legal Investigation - The law firm is encouraging investors who suffered losses in Dow's stock to reach out for discussions regarding their legal rights and potential claims [1][4].

Core Viewpoint - A lawsuit has been filed against Lineage, Inc. and its senior executives for potential violations of federal securities laws related to its IPO and subsequent financial performance [1][2]. Group 1: Lawsuit Details - Investors have until September 30, 2025, to request to lead the case, which is based on claims under Sections 11 and 15 of the Securities Act of 1933 [2]. - The lawsuit is pending in the U.S. District Court for the Eastern District of Michigan, specifically titled City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., et al. [2]. Group 2: Company Overview - Lineage, Inc. operates as a cold storage-focused real estate investment trust (REIT), owning and managing temperature-controlled storage facilities for perishable products [3]. Group 3: Allegations and Financial Performance - The IPO documents claimed strong cash flows due to consistent cold chain demand, suggesting resilience during economic stress, while the reality was a downturn as customers destocked excess inventory from the pandemic [4]. - Following the IPO at $78 per share, Lineage's stock price has significantly declined to around $40 per share, approximately 50% of its initial value [5].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Tempus AI, Inc. regarding possible violations of federal securities laws and other unlawful business practices [1][2] Group 1: Investigation and Claims - The investigation by Bragar Eagel & Squire, P.C. is on behalf of Tempus stockholders [1] - Spruce Point Capital Management published a report raising concerns about Tempus, including aggressive accounting practices and the background of several board members with troubled companies [2] - Following the report, Tempus's stock price experienced a significant decline during intraday trading on May 28, 2025 [2] Group 2: Company Background - Tempus AI, Inc. is publicly traded on NASDAQ under the ticker symbol TEM [2] - Bragar Eagel & Squire, P.C. is a law firm that represents individual and institutional investors in various types of litigation [4]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against e.l.f. Beauty, Inc. due to allegations of misleading statements and inflated financial metrics, with a class action lawsuit deadline set for May 5, 2025 [4][6]. Group 1: Allegations Against e.l.f. Beauty - The complaint alleges that e.l.f. Beauty and its executives violated federal securities laws by making false and misleading statements regarding rising inventory levels and sales performance [6]. - It is claimed that e.l.f. Beauty falsely attributed rising inventory levels to changes in sourcing practices rather than declining sales [6]. - The company reportedly inflated revenue and profits over several quarters to maintain investor confidence, which ultimately overstated its business and financial prospects [6]. Group 2: Impact of Muddy Waters Report - On November 20, 2024, Muddy Waters Research published a report alleging that e.l.f. Beauty had materially overstated revenue over the past three quarters [6]. - The report indicated that management recognized issues with growth narratives as inventory levels increased, leading to inflated revenue reporting [6]. Group 3: Financial Outlook and Adjustments - On February 6, 2025, e.l.f. Beauty revised its fiscal 2025 net sales growth expectations to 27%-28%, down from a previous guidance of 28%-30% [7]. - The adjusted EBITDA guidance was also lowered to $289-293 million from $304-308 million, influenced by the updated sales outlook and a $7 million foreign currency loss [7]. - The company anticipated net sales growth to be between -1% to +2%, reflecting softer consumption trends and slower-than-expected new product performance [7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against e.l.f. Beauty, Inc. due to allegations of misleading financial statements and inflated revenue, with a class action lawsuit deadline set for May 5, 2025 [2][4]. Group 1: Allegations Against e.l.f. Beauty - The complaint alleges that e.l.f. Beauty and its executives violated federal securities laws by making false and misleading statements regarding rising inventory levels and sales performance [4]. - It is claimed that e.l.f. Beauty falsely attributed rising inventory levels to changes in sourcing practices rather than declining sales [4]. - The Muddy Waters Report accused e.l.f. Beauty of materially overstating revenue and profits over several quarters, indicating that the company concealed inventory challenges from investors [4]. Group 2: Financial Performance and Outlook - On February 6, 2025, e.l.f. Beauty revised its fiscal 2025 net sales growth forecast to 27%-28%, down from 28%-30%, and adjusted its EBITDA guidance to $289-293 million, down from $304-308 million [5]. - The company also anticipated net sales growth to be between -1% to +2%, citing softer consumption trends and slower-than-expected new product performance as reasons for the revision [5]. Group 3: Legal Proceedings and Investor Actions - Investors who suffered losses exceeding $50,000 in e.l.f. Beauty between November 1, 2023, and November 19, 2024, are encouraged to contact Faruqi & Faruqi to discuss their legal options [1]. - The lead plaintiff in the class action will be the investor with the largest financial interest who is typical of class members, overseeing the litigation on behalf of the class [5].